Immunome, Inc. (IMNM)
23.42
-0.53
(-2.21%)
USD |
NASDAQ |
Sep 16, 16:00
23.42
0.00 (0.00%)
After-Hours: 16:57
Immunome Market Cap : 2.656B for Sept. 16, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 15, 2026 | 2.716B |
| September 14, 2026 | 2.784B |
| September 11, 2026 | 2.798B |
| September 10, 2026 | 2.832B |
| September 09, 2026 | 2.962B |
| September 08, 2026 | 3.040B |
| September 04, 2026 | 3.035B |
| September 03, 2026 | 3.080B |
| September 02, 2026 | 3.099B |
| September 01, 2026 | 3.069B |
| August 31, 2026 | 3.108B |
| August 28, 2026 | 3.126B |
| August 27, 2026 | 3.274B |
| August 26, 2026 | 3.260B |
| August 25, 2026 | 3.332B |
| August 24, 2026 | 3.176B |
| August 21, 2026 | 3.234B |
| August 20, 2026 | 3.184B |
| August 19, 2026 | 3.382B |
| August 18, 2026 | 3.125B |
| August 17, 2026 | 3.107B |
| August 14, 2026 | 3.084B |
| August 13, 2026 | 2.996B |
| August 12, 2026 | 3.174B |
| August 11, 2026 | 2.977B |
| Date | Value |
|---|---|
| August 10, 2026 | 2.913B |
| August 07, 2026 | 2.838B |
| August 06, 2026 | 2.928B |
| August 05, 2026 | 2.888B |
| August 04, 2026 | 2.836B |
| August 03, 2026 | 2.604B |
| July 31, 2026 | 2.576B |
| July 30, 2026 | 2.612B |
| July 29, 2026 | 2.615B |
| July 28, 2026 | 2.628B |
| July 27, 2026 | 2.555B |
| July 24, 2026 | 2.514B |
| July 23, 2026 | 2.491B |
| July 22, 2026 | 2.589B |
| July 21, 2026 | 2.578B |
| July 20, 2026 | 2.508B |
| July 17, 2026 | 2.526B |
| July 16, 2026 | 2.512B |
| July 15, 2026 | 2.594B |
| July 14, 2026 | 2.557B |
| July 13, 2026 | 2.580B |
| July 10, 2026 | 2.643B |
| July 09, 2026 | 2.735B |
| July 08, 2026 | 2.717B |
| July 07, 2026 | 2.760B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 9.287B |
| Oncolytics Biotech, Inc. | 97.02M |
| Sangamo Therapeutics, Inc. | 61.02M |
| Sarepta Therapeutics, Inc. | 2.086B |
| Anixa Biosciences, Inc. | 89.57M |
Market Cap Related Metrics
| Price to Book Value | 5.058 |
| Price | 23.42 |
| Earnings Yield | -10.79% |